Shoshana Shendelman insider trades: Applied Therapeutics (APLT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shoshana reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | APLT | ↓ Sell | 777,014 | $6.06 | $4.7M | Direct | Aug 14, 2024 (0d) |
| Jun 6, 2024 | APLT | ↓ Sell | 61,795 | $4.32 | $267K | Direct | Jun 10, 2024 (4d) |
| Mar 14, 2024 | APLT | ↓ Sell | 318,573 | $5.39 | $1.7M | Direct | Mar 18, 2024 (4d) |
| Nov 30, 2023 | APLT | ↓ Sell | 3,968 | $1.97 | $8K | Direct | Dec 1, 2023 (1d) |
| Sep 27, 2023 | APLT | ↓ Sell | 115,632 | $2.70 | $312K | Direct | Sep 29, 2023 (2d) |
| Jan 11, 2023 | APLT | ↓ Sell | 15,870 | $0.91 | $14K | Direct | Jan 13, 2023 (2d) |
| Oct 14, 2022 | APLT | ↑ Buy | 50,000 | $0.65 | $32K | Direct | Oct 14, 2022 (0d) |
| Oct 13, 2022 | APLT | ↑ Buy | 73,256 | $0.56 | $41K | Direct | Oct 13, 2022 (0d) |
| Oct 12, 2022 | APLT | ↑ Buy | 38,153 | $0.52 | $20K | Direct | Oct 12, 2022 (0d) |
| Sep 14, 2021 | APLT | ↑ Buy | 10,001 | $14.50 | $145K | Direct | Sep 14, 2021 (0d) |
| Jul 22, 2020 | APLT | ↓ Sell10b5-1 | 45,000 | $26.68 | $1.2M | Direct | Jul 22, 2020 (0d) |
| Jul 9, 2020 | APLT | ↓ Sell10b5-1 | 45,000 | $31.86 | $1.4M | Direct | Jul 9, 2020 (0d) |
| May 28, 2020 | APLT | ↓ Sell | 125,000 | $42.70 | $5.3M | Direct | Jun 1, 2020 (4d) |
| May 16, 2019 | APLT | ↑ Buy | 125,000 | $10.00 | $1.3M | Direct | May 20, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other APLT insiders
Open-market trades in the last 12 months
About Shoshana Shendelman's insider trades
Shoshana Shendelman is President and CEO at Applied Therapeutics (APLT). Since May 16, 2019, Shoshana has reported 5 open-market purchases worth $1.5M and 9 sales worth $15.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (18% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (8 filings), option exercises (3 filings), gifts (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APLT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.